Oxford Biomedica (OXBDF) Stock Price, News & Analysis
Company Description
Oxford Biomedica (OTC Link: OXBDF) is classified in the biotechnology industry within the Healthcare sector and carries a market capitalization of $978.1M.
OXBDF has gained 54.7% over the past year. Shares last traded at $8.00.
This page collects what Stock Titan holds for OXBDF, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Oxford Biomedica (OXBDF) stock last closed at $8.00. Over the past 12 months, the stock has gained 54.7%. At a market capitalization of $978.1M, OXBDF is classified as a small-cap stock with approximately 121.0M shares outstanding.
Latest News
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Short interest in Oxford Biomedica (OXBDF) currently stands at 110.7 thousand shares, up 12.0% from the previous reporting period, representing 0.1% of the float. Since July 2025, short interest has decreased by 65.4%. This relatively low short interest suggests limited bearish sentiment. With 36.9 days to cover, it would take significant time for short sellers to close their positions based on average trading volume.
Days to Cover History
Days to cover for Oxford Biomedica (OXBDF) currently stands at 36.9 days, down 11.6% from the previous period. This elevated days-to-cover ratio indicates it would take over two weeks of average trading volume for short sellers to exit their positions, suggesting potential for a short squeeze if positive news emerges. The days to cover has decreased 90.7% over the past year, suggesting improved liquidity for short covering. The ratio has shown significant volatility over the period, ranging from 2.6 to 1000.0 days.
OXBDF Company Profile & Sector Positioning
Oxford Biomedica (OXBDF) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the OTC Link.
Investors comparing OXBDF often look at related companies in the same sector, including Pharming Group (PHGUF), Nxera Pharma (SOLTF), Pharma Mar Sa (PHMMF), Genus Plc (GENSY), and Sanbio (SNBOY). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate OXBDF's relative position within its industry.